NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep
16 August 2017
NeuroMetrix, Inc. announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,731,126. The patent covers novel technology whereby the Quell® device automatically modu
